Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular risk in genetically defined population with a recent acute coronary syndrome (DALCOR) : NCT02525939

Project: Types of projectsProject

View graph of relations
Period01/10/2016 → …

ID: 61755559